P-044: RETROSPECTIVE STUDY OF POST-TRANSFUSION ALLOIMMUNIZATION IN THE SICKLE CELL POPULATION OF THE CHR CITADELLE

Autor: SEPULCHRE E., MINON J., PARIDAENS H., STOJKOVIC V., KETELSLEGERS O., DRESSE M.

Publikováno v: HemaSphere, Vol 6, Pp 39-39 (2022)

Externí odkaz: https://doaj.org/article/24f2b3704aa546f6b8347b0e6ad7220b

Pancytopenia Due to Vitamin B12 and Folic Acid Deficiency-A Case Report.

Autor: Depuis Z; Department of Pediatrics, University Hospital Liège, Avenue de l'Hôpital 1, 4000 Liege, Belgium., Gatineau-Sailliant S; Department of Pediatrics, University Hospital Liège, Avenue de l'Hôpital 1, 4000 Liege, Belgium., Ketelslegers O; Department of Laboratory Medicine, Regional Hospital of Liège, Boulevard du 12ème de Ligne 1, 4000 Liege, Belgium., Minon JM; Department of Laboratory Medicine, Regional Hospital of Liège, Boulevard du 12ème de Ligne 1, 4000 Liege, Belgium., Seghaye MC; Department of Pediatrics, University Hospital Liège, Avenue de l'Hôpital 1, 4000 Liege, Belgium., Vasbien M; Department of Laboratory Medicine, Regional Hospital of Liège, Boulevard du 12ème de Ligne 1, 4000 Liege, Belgium., Dresse MF; Department of Pediatrics, University Hospital Liège, Avenue de l'Hôpital 1, 4000 Liege, Belgium.

Publikováno v: Pediatric reports [Pediatr Rep] 2022 Mar 03; Vol. 14 (1), pp. 106-114. Date of Electronic Publication: 2022 Mar 03.

Sickle cell disease from Africa to Belgium, from neonatal screening to clinical management

Autor: Lê, P. Q., Ferster, A., Frederic Cotton, Vertongen, F., Vermylen, C., Vanderfaeillie, A., Dedeken, L., Heijmans, C., Ketelslegers, O., Dresse, M. F., Gulbis, B.

Publikováno v: Scopus-Elsevier
Europe PubMed Central

To describe the severity of sickle cell disease (SCD) in newborns in Belgium and evaluate the impact of neonatal screening (NS) on clinical outcome.Universal NS of umbilical cord blood for hemoglobinopathy was progressively deployed in Brussels and L

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::33d3e61aff642c81183930c9a6ff2887
https://pubmed.ncbi.nlm.nih.gov/21516988

Newborn Screening for Sickle Cell Disease in Europe.

Autor: Daniel Y; Public Health England, NHS Sickle Cell and Thalassemia Screening Programme, London SE16LH, UK., Elion J; Laboratoire d'Excellence GR-Ex, UMR_S1134, Inserm, Université Paris Diderot, Sorbonne Paris Cité, Institut National de la Transfusion Sanguine, 75015 Paris, France., Allaf B; NBS Laboratory for Haemoglobinopathies, Hôpital Universitaire Robert-Debré, 75019 Paris, France., Badens C; Département de génétique médicale, Aix-Marseille Université, Hôpital de la Timone, 13385 Marseille, France., Bouva MJ; National Institute for Public Health and the Environment, Centre for Health Protection, 3720 Bilthoven, The Netherlands., Brincat I; Pediatric Medicine Laboratory, Department of Pathology, Mater Dei Hospital, Triq Tal-Qroqq, MSD2090 Msida, Malta., Cela E; Department of Pediatric Oncology/Hematology, Hospital Universitario General Gregorio Marañón, Facultad de Medicina, Universidad Complutense Madrid, 28007 Madrid, Spain., Coppinger C; Public Health England, NHS Sickle Cell and Thalassemia Screening Programme, London SE16LH, UK., de Montalembert M; Department of Pediatrics, Reference Center for Sickle Cell Disease, AP-HP Hôpital Universitaire Necker-Enfants Malades, 75743 Paris, France., Gulbis B; Department of Clinical Chemistry, Cliniques Universitaires de Bruxelles, Hôpital Erasme-ULB, 1070 Bruxelles, Belgium., Henthorn J; Public Health England, NHS Sickle Cell and Thalassemia Screening Programme, London SE16LH, UK., Ketelslegers O; Laboratoire-Biologie Clinique, Centre Hospitalier Régional de la Citadelle, 4000 Liège, Belgium., McMahon C; Our Lady's Children's Hospital, Crumlin, D12V004 Dublin, Ireland., Streetly A; School of Population Health and Environmental Sciences, Faculty of Life Sciences & Medicine, King's College London, London WC2R2LS, UK.; Division of Healthcare Public Health, Health Protection and Medical Directorate, Public Health England, London SE18UG, UK., Colombatti R; Department of Child and Maternal Health, Clinic of Pediatric Hematology/Oncology, Azienda Ospedaliera-Università di Padova, 35129 Padova, Italy., Lobitz S; Department of Pediatric Oncology/Hematology, Kinderkrankenhaus Amsterdamer Straße, 50735 Cologne, Germany.

Publikováno v: International journal of neonatal screening [Int J Neonatal Screen] 2019 Feb 12; Vol. 5 (1), pp. 15. Date of Electronic Publication: 2019 Feb 12 (Print Publication: 2019).

Neonatal screening improves sickle cell disease clinical outcome in Belgium.

Autor: Lê PQ; 1 Hemato-Oncology, Hopital Universitaire des Enfants Reine Fabiola, Brussels, Belgium., Ferster A; 1 Hemato-Oncology, Hopital Universitaire des Enfants Reine Fabiola, Brussels, Belgium., Dedeken L; 1 Hemato-Oncology, Hopital Universitaire des Enfants Reine Fabiola, Brussels, Belgium., Vermylen C; 2 Hemato-Oncology, Cliniques Universitaires Saint-Luc, Brussels, Belgium., Vanderfaeillie A; 3 Pediatrics, Centre Hospitalier Universitaire Saint-Pierre, Brussels, Belgium., Rozen L; 4 Laboratory of Hematology and Hemostasis, Centre Hospitalier Universitaire de Brugmann, Brussels, Belgium., Heijmans C; 1 Hemato-Oncology, Hopital Universitaire des Enfants Reine Fabiola, Brussels, Belgium., Huybrechts S; 1 Hemato-Oncology, Hopital Universitaire des Enfants Reine Fabiola, Brussels, Belgium., Devalck C; 1 Hemato-Oncology, Hopital Universitaire des Enfants Reine Fabiola, Brussels, Belgium., Cotton F; 5 Clinical Chemistry, Erasme Hospital, Brussels, Belgium., Ketelslegers O; 6 Clinical Chemistry, Centre Hospitalier Regional de la Citadelle, Belgium., Dresse MF; 7 Hemato-Oncology, Centre Hospitalier Regional de la Citadelle, Belgium., Fils JF; 8 Independant Biostatistician - Ars Statistica, Belgium., Gulbis B; 5 Clinical Chemistry, Erasme Hospital, Brussels, Belgium.

Publikováno v: Journal of medical screening [J Med Screen] 2018 Jun; Vol. 25 (2), pp. 57-63. Date of Electronic Publication: 2017 Jul 07.